Atovaquonestructure (Atovaquonestructure)
Atovaquone Suspension
Product Images NDC 31722-629
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 31722-629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Address1 (Address1)
Atovaquoneoscartonlabel (Atovaquoneoscartonlabel)
Atovaquoneoscontlabel (Atovaquoneoscontlabel)
Each 5mL of this suspension contains 750 mg of Atovaquone USP. Refer to the prescribing information to know the usual dosage and administration. It is necessary to store the suspension at a temperature between 15°C to 25°C (59°F to 77°F), and avoid freezing it. Dispense it in a tight container as per the definition given in USP, and one must shake it gently before use. The US contact number is 1-866-495-1995. This oral suspension is manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ 08854. The size of the label is 40mm x 30mm, and the unvarnished area is small. The NDC code for this medication is 31722-629-21. The manufacturer is Hetero Labs Limited, Jeedimetla, Hyderabad-500055, India. However, the last line seems to contain non-English characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
